IDH1 inhibitor gets orphan designation for AMLJune 12, 2015Leukemia, Myelodysplasia, TransplantationPharmacyAML
LSC phenotypes correlate with prognosis in AMLJune 4, 2015Leukemia, Myelodysplasia, TransplantationAML
FDA grants inhibitor fast track designation for AMLMay 19, 2015Leukemia, Myelodysplasia, TransplantationPharmacyAML
Combo targets AML, BL in the same wayMay 17, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLNon-Hodgkin Lymphoma
FDA grants drug orphan designation for AMLMay 15, 2015Leukemia, Myelodysplasia, TransplantationPharmacyAML
Susceptibility to 2nd cancers in WM/LPL survivorsApril 30, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLHodgkin LymphomaNon-Hodgkin Lymphoma
CDK inhibitor proves active against AML, ALLApril 26, 2015Leukemia, Myelodysplasia, TransplantationAMLALL
AML study shows transcription factors are ‘druggable’March 27, 2015Leukemia, Myelodysplasia, TransplantationAML
